Short-term treatment with rivastigmine and plasma levels of Ab peptides in Alzheimer’s disease

Journal Title: Folia Neuropathologica - Year 2005, Vol 43, Issue 4

Abstract

Deregulation of APP metabolism is considered to be a key pathogenic event in Alzheimer’s disease. Data from cell cultures indicate that the secretion of Ab1-42 might be inhibited by cholinesterase inhibitors, possibly via M1 receptors stimulation. Treatment with tacrine, a dual acetyl- and butyrylcholinesterase inhibitor, had no significant effect on mean plasma Ab species concentrations. However, a correlation was observed between higher drug concentrations and lower Ab levels that might indicate an effect on APP metabolism with an increased a-cleavage. Ab1-40 and Ab1-42 levels were measured in the plasma of 28 AD subjects by means of a commercially available ELISA before rivastigmine treatment and at week 2 after the first dose of the drug (3 mg/day) had been administered. Treatment with rivastigmine exhibited a significant effect on mean plasma concentrations of Ab1-42 (mean difference 7.8±8.4, t=-4.9, pmean difference 7.8±8.4, t=-4.9, p

Authors and Affiliations

Tomasz Sobow, Iwona Kloszewska

Keywords

Related Articles

Plaques and tangles and the pathogenesis of Alzheimer’s disease

Since the earliest descriptions, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological hallmarks of Alzheimer’s disease (AD). Consequently, studies of the morphology, distribution...

CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone)

The MCP-1 and RANTES levels were measured in 20 multiple sclerosis patients before and after 1 year daily treatment with 20 mg of subcutaneously applied glatiramer acetate. The level of MCP-1 in serum from multiple scler...

The effect of propofol on astro- and microglial reactivity in the course of experimental intracerebral haemorrhage in rats

The glial cells play an important role in pathophysiology of the intracerebral haemorrhage (ICH). Thus the attempt at evaluating the possible influence of the propofol on the reactivity of astro- and microglial cells i...

Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases

Leukoencephalopathy with vanishing white matter (VWM), also called childhood ataxia with central nervous system hypomyelination (CACH), is an autosomal recessive disease caused by mutations in any of the five genes encod...

Download PDF file
  • EP ID EP144326
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Tomasz Sobow, Iwona Kloszewska (2005). Short-term treatment with rivastigmine and plasma levels of Ab peptides in Alzheimer’s disease. Folia Neuropathologica, 43(4), 340-344. https://europub.co.uk./articles/-A-144326